DK233088D0 - PEPTID WITH PROTECTED C-TERMINAL ALFA CARBOXYL GROUP OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, ITS MANUFACTURE AND USE AS A PHARMACEUTICAL - Google Patents

PEPTID WITH PROTECTED C-TERMINAL ALFA CARBOXYL GROUP OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, ITS MANUFACTURE AND USE AS A PHARMACEUTICAL

Info

Publication number
DK233088D0
DK233088D0 DK233088A DK233088A DK233088D0 DK 233088 D0 DK233088 D0 DK 233088D0 DK 233088 A DK233088 A DK 233088A DK 233088 A DK233088 A DK 233088A DK 233088 D0 DK233088 D0 DK 233088D0
Authority
DK
Denmark
Prior art keywords
peptid
pharmaceutical
protected
manufacture
acceptable salts
Prior art date
Application number
DK233088A
Other languages
Danish (da)
Other versions
DK233088A (en
Inventor
Wolfgang Koenig
Peter Schindler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK233088D0 publication Critical patent/DK233088D0/en
Publication of DK233088A publication Critical patent/DK233088A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK233088A 1987-04-29 1988-04-28 PEPTID WITH PROTECTED C-TERMINAL ALFA CARBOXYL GROUP OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, ITS MANUFACTURE AND USE AS A PHARMACEUTICAL DK233088A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3714277 1987-04-29

Publications (2)

Publication Number Publication Date
DK233088D0 true DK233088D0 (en) 1988-04-28
DK233088A DK233088A (en) 1988-10-30

Family

ID=6326516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK233088A DK233088A (en) 1987-04-29 1988-04-28 PEPTID WITH PROTECTED C-TERMINAL ALFA CARBOXYL GROUP OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, ITS MANUFACTURE AND USE AS A PHARMACEUTICAL

Country Status (8)

Country Link
EP (1) EP0288965A2 (en)
JP (1) JPS63284197A (en)
KR (1) KR880012640A (en)
AU (1) AU1526388A (en)
DK (1) DK233088A (en)
IL (1) IL86195A0 (en)
PT (1) PT87350B (en)
ZA (1) ZA883033B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK15888D0 (en) * 1988-01-14 1988-01-14 Carlsberg Biotechnology Ltd ENZYMATIC PROCEDURE FOR PREPARING IMMUNO MODULATING PENTAPEPTIDES AND INTERMEDIATES FOR USING THE PROCEDURE
US5079260A (en) * 1989-06-22 1992-01-07 Nova Pharmaceutical Corporation Method for treating inflammation and compounds and compositions suitable for use therein
JP2960947B2 (en) * 1989-12-25 1999-10-12 日清製粉株式会社 Lipolytic enzyme inhibitors
US5376640A (en) * 1989-12-25 1994-12-27 Nisshin Flour Milling Co., Ltd. Lipolytic enzyme inhibitors
GB2239455B (en) * 1989-12-25 1993-12-15 Nisshin Flour Milling Co Formulations of lipolytic enzyme inhibitors and use of said inhibitors
EP0592553B1 (en) * 1991-07-04 1999-05-12 Garvan Institute Of Medical Research Pla2 inhibitory compounds
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
GB9206757D0 (en) * 1992-03-27 1992-05-13 Ferring Bv Novel peptide receptor ligands
GB9422294D0 (en) * 1994-11-04 1994-12-21 Peptide Therapeutics Ltd Peptides for anti-allergy treatment
AP9600817A0 (en) 1995-06-06 1996-07-31 Pfizer Novel cryatal form of anhydrous 7-( [1A,5A,6A]-6-amino3-3-azabicyclo [3.1.0.] hex-3-yl) -6-fluro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1, 8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt.
MY114711A (en) 1995-06-06 2002-12-31 Pfizer Substituted n-(indole-2-carbonyl)-b-alanmamides and derivatives as antidiabetic agents
JP3314938B2 (en) * 1995-06-06 2002-08-19 ファイザー・インコーポレーテッド Substituted N- (indole-2-carbonyl) -glycinamides and derivatives as glycogen phosphorylase inhibitors
ATE311383T1 (en) 1996-08-22 2005-12-15 Warner Lambert Co NON-PEPTIDIC BOMBESIN RECEPTOR ANTAGONISTS
US6737408B1 (en) 1997-08-07 2004-05-18 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
CA2321926C (en) * 1998-02-24 2010-04-27 Tatjana Piljac Use of rhamnolipids in a composition for the treatment of signs of aging
AU2001270098A1 (en) * 2000-06-22 2002-01-02 San Diego State University Foundation Recombination modulators and methods for their production and use
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
US20070197445A1 (en) 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite

Also Published As

Publication number Publication date
JPS63284197A (en) 1988-11-21
AU1526388A (en) 1988-11-03
DK233088A (en) 1988-10-30
IL86195A0 (en) 1988-11-15
KR880012640A (en) 1988-11-28
PT87350B (en) 1992-08-31
PT87350A (en) 1988-05-01
EP0288965A2 (en) 1988-11-02
ZA883033B (en) 1988-11-01

Similar Documents

Publication Publication Date Title
DK233088D0 (en) PEPTID WITH PROTECTED C-TERMINAL ALFA CARBOXYL GROUP OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, ITS MANUFACTURE AND USE AS A PHARMACEUTICAL
DK304488A (en) SUSTAINABLE PEPTIDES OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF AND THEIR USE AND INTERMEDIATES FOR ITS MANUFACTURING
NO873298L (en) ORAL THERAPEUTIC SYSTEM WITH SYSTEMATIC EFFECT.
NO892834L (en) IMIDOPEROXICARBOXYLIC ACIDS, ITS MANUFACTURE AND USE.
DE3689246D1 (en) Physiologically active polypeptide BUF-3.
DK143588A (en) SUBSTITUTED 9-AMINO-TETRAHYDROACRIDINES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK209188D0 (en) BIFUNCTIONAL PROTEINS, THEIR PREPARATION AND USE AS A MEDICINE
DK55088A (en) 3,4-DIHYDRO-2H-BENZO (B) PYRANES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK131887D0 (en) 1,2,3,4-TETRAHYDRO-3-CARBAMOYL-2-THIOXO / OXO-5-PYRIMIDENCARBOXYLIC ACID DERIVATIVES AND THEIR USE AS MEDICINES
DK166214C (en) GNRH-ANTAGONISTIC PEPTIDE AND PHARMACEUTICAL ACCEPTABLE SALTS AND PHARMACEUTICAL PREPARATION CONTAINING THE PEPTID
DK366888D0 (en) CASTANOSPERMINESTERS AND GYCOSIDES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK103987D0 (en) SUBSTITUTED 1,3,4,9-TETRAHYDROPYRANOE3,4-BAAINDOL-L-ACETIC ACIDS, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK69389D0 (en) PURE-INHIBITED AMINO ACID DERIVATIVES AND PHYSIALLY ACCEPTABLE SALTS THEREOF, THEIR PREPARATION AND USE
DE3886517D1 (en) Human prourokinase-like polypeptide.
NO894532L (en) TITANIUM Dioxide, PROCEDURE FOR ITS MANUFACTURING AND USE THEREOF.
NO892744D0 (en) N-TERMINAL AMINODIOL AMINO ACID DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
DK144885D0 (en) SUBSTITUTED 4-HYDROXYBENZOPYRANES OR PHARMACEUTICAL ACCEPTABLE ADDITIONAL SALTS THEREOF, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK543788D0 (en) PURE-INHIBITING DIPEPTIDES OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, THEIR PREPARATION AND USE
DK513188A (en) AMINO ACID ESTERS, THEIR PREPARATION AND USE AS PHARMACEUTICALS
DK421389D0 (en) AMINOMETHYL PEPTIDES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK192588D0 (en) PYRROLALDEHYDES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND USE
DK42888D0 (en) ARYLTHIADIAZOLYL SULPHONAMIDES AND DERIVATIVES THEREOF, THEIR PREPARATION AND USE AS A MEDICINE
DK47788D0 (en) 14,15-SUBSTITUTED LANOSTEROLS AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF AND THEIR USE AS PHARMACEUTICALS
IT8748235A0 (en) PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
DK238786A (en) BICYCLIC AMINO ACIDS OR PHYSIOLOGICALLY HAZARDOUS SALTS THEREOF, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS AND INTERMEDIATE PRODUCTS AND THEIR PREPARATION

Legal Events

Date Code Title Description
ATS Application withdrawn